Discover an informative webinar to learn how innovative solutions and collaborative efforts are transforming psychiatry clinical research.
Psychiatry clinical research involves distinctive challenges that make it difficult to achieve reliable study outcomes. As a result, these challenges hinder the ability to bring new and effective treatment options to the patients who need them. The diversity of psychiatric disorders, the subjective nature of diagnosis and the strong placebo effect obscure the true efficacy of interventions. Moreover, poor medication adherence and patient retention issues undermine the reliability and effectiveness of clinical trials.
In this upcoming webinar, the expert speakers will dive into these critical challenges and explore innovative solutions designed to enhance the accuracy and reliability of psychiatry clinical research. This webinar is tailored for researchers, clinicians and stakeholders aiming to improve patient outcomes and streamline research processes.
One of the primary issues is the high incidence of placebo responses, which can significantly skew study results. In this webinar, the expert speakers will discuss cutting-edge methodologies and best practices for managing and mitigating placebo effects, ensuring more robust and conclusive findings. A key focus will be innovative medication adherence services, which are crucial in reducing placebo impacts by promoting consistent and accurate medication use among participants.
Patient recruitment and retention remains a significant challenge in clinical research. The expert speakers will share insights from the accelerated enrollment solutions (AES) sites and highlight successful strategies for maintaining high retention rates. They will focus on how to enhance participant engagement and retention, leading to more reliable and comprehensive data.
Additionally, the expert speakers will share how business resource groups (BRGs), which comprise individuals with lived experiences in the psychiatry space, provide invaluable perspectives and support to research initiatives and help bridge the gap between clinical research and real-world patient experiences.
Register for the webinar to discover effective strategies for managing placebo responses, improving patient retention and leveraging the power of lived experiences to advance mental health research.
Speakers
Sabine Krofczik-Wilhelm, PhD, Executive Director and Pillar Head of the Neurodegenerative and Psychiatry, PPD clinical research business of Thermo Fisher Scientific
Sabine Krofczik-Wilhelm, PhD, is a dynamic Executive Director of project management at Thermo Fisher Scientific located in Lisbon, Portugal. With 17+ years in the pharmaceutical industry, she excels in leading global teams and driving neuroscience projects to success. Sabine holds a PhD in Neurobiology from the Free University in Berlin and is currently pursuing a Master’s in Longevity Sciences at the Geneva College of Longevity Sciences.
As a passionate agile leader, she is dedicated to pioneering treatments for dementia and psychiatric conditions. Sabine’s commitment to innovation and excellence makes her a key player in advancing healthcare solutions.
Message Presenter
Dr. Bethany B. Davis, MD, Medical Director of Psychiatry and Neurology, Accelerated Enrollment Solutions (AES), PPD clinical research business of Thermo Fisher Scientific
Dr. Bethany Davis, MD is a Board-Certified Psychiatrist and Principal Investigator based in Atlanta, GA. With over 15 years of experience in clinical trials (Phase II-IV) within the pharmaceutical industry, she has extensive expertise in every facet of clinical trial execution across nearly all psychiatric indications. As the Medical Director for the Psychiatry and Neurology therapeutic areas, Dr. Davis offers clinical insights into study design, site capabilities and best practices, ensuring the highest standards of subject safety and data integrity throughout the course of clinical trials.
Message Presenter
Dr. Anna Gonzaga, MD, Medical Director, PPD clinical research business of Thermo Fisher Scientific
Dr. Anna Gonzaga, MD, is a Medical Director at PPD clinical research business of Thermo Fisher Scientific. She received her medical degree from the Medical College of Ohio in 1997 and completed a residency in General Psychiatry at Duke University Medical Center in 2001. She then moved to Maryland for a fellowship in Child and Adolescent Psychiatry at Johns Hopkins Hospital.
After graduating from the fellowship in 2003, Dr. Gonzaga remained at Hopkins to work at Johns Hopkins Bayview Medical Center’s Community Psychiatry Program (CPP). At CPP, she evaluated and treated patients in a variety of settings, including the Child Outpatient Clinic and the school-based program. In her over 20 years of clinical experience, Dr. Gonzaga cared for hundreds of patients with Attention-Deficit/Hyperactivity Disorder.
Since joining the PPD clinical research business of Thermo Fisher Scientific in November 2021, Dr. Gonzaga has served as a medical monitor for Phase I through III psychiatry and neurology programs.
Message Presenter
Omar Moreira, MS, Patient Recruitment Lead – Patient Enrollment Optimization, Patient First Digital Solutions, PPD clinical research business of Thermo Fisher Scientific
Mr. Omar Moreira has over 10 years of clinical research experience in psychiatry, neurology and inflammatory bowel disorders, along with two years of providing therapeutic services to psychiatric populations and holds a master’s in Clinical Psychology. He has held various roles in clinical trials, including Clinical Rater, Project Manager and Business Development Manager for Phase I-IV studies. His expertise extends to patient recruitment and identification, working closely to optimize enrollment strategies.
Currently serving as a Patient Recruitment Lead, Mr. Moreira develops targeted recruitment strategies, analyzes trends in patient symptomatology presentations, screens failures and early terminations and provides operational insights to enhance site efficiency. His focus is on streamlining recruitment processes and improving patient retention, ensuring the success of clinical trials through data-driven decision-making and site support.
Message PresenterWho Should Attend?
This webinar will appeal to those working in the following areas or having the following job titles:
- Biotech/Biopharma sponsors interested in psychiatry assets
- Healthcare Providers/Clinicians
- Clinical Research Investigators/Site Directors
- Stakeholders aiming to improve patient outcomes and streamline research processes
What You Will Learn
Attendees will gain insights into:
- The critical challenges and innovative solutions designed to enhance the accuracy and reliability of psychiatry clinical research
- Innovative medication adherence services, which are crucial in reducing placebo impacts by promoting consistent and accurate medication use among participants
- Leveraging community partnerships to help build trust in the community to enhance participant engagement and retention, leading to more reliable and comprehensive data
- Effective strategies for managing placebo responses, improving patient recruitment and retention, and leveraging the power of lived experiences to advance mental health research
Xtalks Partner
The PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account